Stay updated on Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The Publications section now states that entries are automatically filled from PubMed, and a revision tag v3.3.2 was added. The previous PubMed-origin description and the older revision tag v3.2.0 were removed.
    Difference
    0.1%
    Check dated 2025-11-24T21:03:45.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page no longer displays the government funding lapse notice regarding updates and operating status. Core study content, eligibility criteria, and results information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T18:23:38.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No significant additions or deletions detected in the core study information (title, condition, interventions, outcomes, eligibility, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:05:52.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T17:42:30.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Removed several disease/classification terms (neoplasms and carcinoma-related entries) and added a version update to v3.1.0.
    Difference
    0.5%
    Check dated 2025-09-28T11:17:07.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The page revision updates from v3.0.1 to v3.0.2. The 'Back to Top' UI element has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:52:21.000Z thumbnail image

Stay in the know with updates to Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.